Fig. 3From: An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patientsKaplan–Meier survival analysis curves between the low- and high-risk groups. The survival analysis of patients’ OS in the whole cohort (A), age ≥ 65 (B), age < 65 (C), grade I–II (D), grade III (E), stage I–II (F), stage III–IV (G), with neoplasm (H), and without neoplasm (I)Back to article page